Canadian consumers have already spent more than $4.1 million on Artecoll alone. And that's just a piece of the cosmetic injectables market.
Q-MED Canada's general manager, Andre Maraldo, says consumers have so far spent about $6 million on his company's hyaluronic acid injectables — sold as Perlane and Restylane — with sales doubling every year over the past three years.
Maraldo happily lists Artecoll's flaws but says there's no campaign under way to undermine Canderm's product.
"That's ridiculous," he says, adding that concerns, such as those expressed by the Swiss health authorities, reflect a real problem. "That's not something I fabricated. It's factual."
Reprinted with permission from the Toronto Star
Some of the links that appear in this article may have been sponsored by a third-party for commercial purposes.
This information is not to substitute for professional medical advice. You
should not use this information to diagnose or treat a health problem or
disease without consulting with a qualified healthcare provider. Please
consult your healthcare provider with any questions or concerns you may have
regarding your condition.
